Gilead Sciences : GILD

All Gilead Sciences Articles

730 Articles

Jon C. Ogg | Sep 9, 2010 at 8:24 AM EDT

Top Analyst Upgrades and Downgrades (AMGN, AU, BP, BIIB, CELG, GILD, HMY, HGSI, LYG, MPEL, MVIS, RIMM, TEVA, VPHM, WBD)

These are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls: Amgen Inc.…

Jon C. Ogg | Jul 26, 2010 at 8:56 AM EDT

Top Day Trader Alerts (ARNA, ARMH, BP, GENZ, GILD, FSLR, ONXX)

Many stocks are on the move for day traders and active traders this morning. Oddly, most are not on earnings. …

Jon C. Ogg | Jul 23, 2010 at 2:15 PM EDT

Looking at Genzyme’s Peers for ‘Other Buyout Candidate’ Probabilities (GENZ, SNY, GILD, CELG, BIIB, LIFE, HGSI, DNDN)

Genzyme Corporation (NASDAQ: GENZ) is flying high on reports that Sanofi-Aventis (NYSE: SNY) may have an interest in buying the…

Jon C. Ogg | Jul 21, 2010 at 9:00 AM EDT

Top Day Trader Alerts (AAPL, BP, APA, CYT, GILD, GENZ, SQNM, YHOO, VMW, EMC)

Day traders and active traders have many big movers to watch this morning. We are seeing key moves in Apple…

Jon C. Ogg | Jul 21, 2010 at 8:24 AM EDT

Top Analyst Upgrades & Downgrades (NLY, APA, STD, GMR, GILD, GS, HOG, WFR, STX, SQNM, SFL, STT, YHOO)

These are some of this Wednesday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls: Annaly Capital…

Jon C. Ogg | May 25, 2010 at 8:20 AM EDT

Top Analyst Upgrades and Downgrades (AIXG, BK, COCO, EMC, GILD, MIR, MUR, NBG, NTAP, PNC, RRI, LCC, WERN)

These are some of the top analyst upgrades, downgrades, and initiations seen early this Tuesday morning in Wall Street research…

Jon C. Ogg | Apr 21, 2010 at 2:32 PM EDT

BioHealth Business Daily (AGEN, ARRY, GENZ, GILD, HGSI, NPSP, QLTI, RPTP, STEM, BBH, IBB, PBE)

Today’s version of the BioHealth Business Daily is rather different as we have a big disappointment from one of the…

Jon C. Ogg | Apr 21, 2010 at 8:25 AM EDT

Top 10 Analyst Upgrades and Downgrades (AAPL, CSIQ, CIEN, SCHW, EXC, GG, GILD, RIG, VMW, VITC)

These are ten of the top research calls of upgrades, downgrades, and initiations seen from Wall Street firms this Wednesday…

Douglas A. McIntyre | Feb 6, 2010 at 12:23 PM EST

The Unusual Suspects (AMAG, AAPL, BIDU, DENN, APD, ARG, MU, GILD, XNPT)

This past week was filled with many surprises and earnings are still coming on strong. We wanted to look at some…

Douglas A. McIntyre | Dec 30, 2009 at 8:19 AM EST

Top Analyst Upgrades and Downgrades (AAPL, ARCL, GILD, GTEC, MRVL, NVDA)

This Wednesday is looking thinner than normal trading days for analyst upgrades and downgrades seen in Wall Street research calls. …

Douglas A. McIntyre | Dec 15, 2009 at 8:31 AM EST

Top Day Trader Alerts (WFC, JASO, LIMS, ARRY, GILD)

This morning’s top day trader and active trader alerts are below with links to VSInvestor.com on each stock story with…

Douglas A. McIntyre | Sep 2, 2009 at 8:21 AM EDT

Top Analyst Upgrades and Downgrades (BIIB, FRX, GENZ, GILD, HOLX, LVS, MOS, NVAX, RIG, TXT)

These are the top ten analyst research initiations, upgrades, and downgrades we have seen from top Wall Street firms early…

Douglas A. McIntyre | Jul 22, 2009 at 7:53 AM EDT

Top Day Trader Alerts (CIT, ONXX, HGSI, WINN, OFG, AAPL, AMD, YHOO, SBUX, AMLN, GILD)

The following are some of the top stocks to watch for active trading today based on pre-market and after-hours volume…

Douglas A. McIntyre | Jul 22, 2009 at 4:01 AM EDT

The Next Blockbuster Drugs: A $170 Billion Opportunity

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line…

Douglas A. McIntyre | Jul 13, 2009 at 10:25 AM EDT

Biotech & BioHealth Business Daily (PFE, MRK, BAX, BDSI, SPPI, GNBT, AVII, CEGE, BBH, GILD, LLY, SNY, BMY, OSIP)

Here are some of today’s top stories affecting key drug and biotech stocks, accompanied with links through to more detailed…

1 … 45 46 47 48 49

Gilead Sciences : GILD

All Gilead Sciences Articles

Top Analyst Upgrades and Downgrades (AMGN, AU, BP, BIIB, CELG, GILD, HMY, HGSI, LYG, MPEL, MVIS, RIMM, TEVA, VPHM, WBD)

Top Day Trader Alerts (ARNA, ARMH, BP, GENZ, GILD, FSLR, ONXX)

Looking at Genzyme’s Peers for ‘Other Buyout Candidate’ Probabilities (GENZ, SNY, GILD, CELG, BIIB, LIFE, HGSI, DNDN)

Top Day Trader Alerts (AAPL, BP, APA, CYT, GILD, GENZ, SQNM, YHOO, VMW, EMC)

Top Analyst Upgrades & Downgrades (NLY, APA, STD, GMR, GILD, GS, HOG, WFR, STX, SQNM, SFL, STT, YHOO)

Top Analyst Upgrades and Downgrades (AIXG, BK, COCO, EMC, GILD, MIR, MUR, NBG, NTAP, PNC, RRI, LCC, WERN)

BioHealth Business Daily (AGEN, ARRY, GENZ, GILD, HGSI, NPSP, QLTI, RPTP, STEM, BBH, IBB, PBE)

Top 10 Analyst Upgrades and Downgrades (AAPL, CSIQ, CIEN, SCHW, EXC, GG, GILD, RIG, VMW, VITC)

The Unusual Suspects (AMAG, AAPL, BIDU, DENN, APD, ARG, MU, GILD, XNPT)

Top Analyst Upgrades and Downgrades (AAPL, ARCL, GILD, GTEC, MRVL, NVDA)

Top Day Trader Alerts (WFC, JASO, LIMS, ARRY, GILD)

Top Analyst Upgrades and Downgrades (BIIB, FRX, GENZ, GILD, HOLX, LVS, MOS, NVAX, RIG, TXT)

Top Day Trader Alerts (CIT, ONXX, HGSI, WINN, OFG, AAPL, AMD, YHOO, SBUX, AMLN, GILD)

The Next Blockbuster Drugs: A $170 Billion Opportunity

Biotech & BioHealth Business Daily (PFE, MRK, BAX, BDSI, SPPI, GNBT, AVII, CEGE, BBH, GILD, LLY, SNY, BMY, OSIP)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

Gilead Sciences : GILD

All Gilead Sciences Articles

Top Analyst Upgrades and Downgrades (AMGN, AU, BP, BIIB, CELG, GILD, HMY, HGSI, LYG, MPEL, MVIS, RIMM, TEVA, VPHM, WBD)

Top Day Trader Alerts (ARNA, ARMH, BP, GENZ, GILD, FSLR, ONXX)

Looking at Genzyme’s Peers for ‘Other Buyout Candidate’ Probabilities (GENZ, SNY, GILD, CELG, BIIB, LIFE, HGSI, DNDN)

Top Day Trader Alerts (AAPL, BP, APA, CYT, GILD, GENZ, SQNM, YHOO, VMW, EMC)

Top Analyst Upgrades & Downgrades (NLY, APA, STD, GMR, GILD, GS, HOG, WFR, STX, SQNM, SFL, STT, YHOO)

Top Analyst Upgrades and Downgrades (AIXG, BK, COCO, EMC, GILD, MIR, MUR, NBG, NTAP, PNC, RRI, LCC, WERN)

BioHealth Business Daily (AGEN, ARRY, GENZ, GILD, HGSI, NPSP, QLTI, RPTP, STEM, BBH, IBB, PBE)

Top 10 Analyst Upgrades and Downgrades (AAPL, CSIQ, CIEN, SCHW, EXC, GG, GILD, RIG, VMW, VITC)

The Unusual Suspects (AMAG, AAPL, BIDU, DENN, APD, ARG, MU, GILD, XNPT)

Top Analyst Upgrades and Downgrades (AAPL, ARCL, GILD, GTEC, MRVL, NVDA)

Top Day Trader Alerts (WFC, JASO, LIMS, ARRY, GILD)

Top Analyst Upgrades and Downgrades (BIIB, FRX, GENZ, GILD, HOLX, LVS, MOS, NVAX, RIG, TXT)

Top Day Trader Alerts (CIT, ONXX, HGSI, WINN, OFG, AAPL, AMD, YHOO, SBUX, AMLN, GILD)

The Next Blockbuster Drugs: A $170 Billion Opportunity

Biotech & BioHealth Business Daily (PFE, MRK, BAX, BDSI, SPPI, GNBT, AVII, CEGE, BBH, GILD, LLY, SNY, BMY, OSIP)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026